Siga Technologies SIGA
NASDAQ SIGA
$2.96 -0.15 (-4.79%)
At close: Aug 20, 2026 · 12:49 PM UTC

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025)

Siga Technologies' (SIGA) quarterly Total Non-Current Liabilities came in at $18.0 million in Q4 2025, down 28.97% YoY from $25.3 million in Q4 2024, and down 27.57% on a QoQ basis from $24.8 million in Q3 2025.

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has 16 years of Total Non-Current Liabilities data on file, last reported at $18.0 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 28.97% year-over-year to $18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.0 million (down 28.97% YoY) and the FY2025 annual result came in at $18.0 million, down 28.97% from the prior year.
  • Total Non-Current Liabilities fell to $18.0 million in Q4 2025, from $24.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $74.8 million in Q1 2024 to a low of $10.4 million in Q1 2021.
  • A 5-year average of $25.7 million and a median of $22.5 million in 2021 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 304.9% — and 2025, when it sank 62.84%.
  • Tracing SIGA's Total Non-Current Liabilities over 5 years: stood at $33.9 million in 2021, then sank by 36.51% to $21.5 million in 2022, then surged by 151.5% to $54.1 million in 2023, then slumped by 53.19% to $25.3 million in 2024, then dropped by 28.97% to $18.0 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $18.0 million (Q4 2025), $24.8 million (Q3 2025), and $22.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 334.00 Mn
10 Siga Technologies 212.31 Mn 57.34 Mn - 17.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.99 Mn
Sep 30, 2025 24.84 Mn
Jun 30, 2025 22.72 Mn
Mar 31, 2025 27.80 Mn
Dec 31, 2024 25.33 Mn
Sep 30, 2024 22.30 Mn
Jun 30, 2024 21.38 Mn
Mar 31, 2024 74.81 Mn
Dec 31, 2023 54.12 Mn
Sep 30, 2023 30.74 Mn
Jun 30, 2023 18.99 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 21.52 Mn
Sep 30, 2022 27.46 Mn
Jun 30, 2022 16.69 Mn
Mar 31, 2022 10.64 Mn
Dec 31, 2021 33.89 Mn
Sep 30, 2021 22.66 Mn
Jun 30, 2021 11.67 Mn
Mar 31, 2021 10.36 Mn